Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages

Cancer Letters

Volumn 276, Issue 1, 2009, Pages 38-46

  Wong, Carmen P ^a   Bray, Tammy M ^a,b   Ho, Emily ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Immune response; Inflammation; Macrophage; Prostate cancer

Indexed keywords

ANDROGEN; BIOLOGICAL MARKER; ESTROGEN RECEPTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL STRAIN LNCAP; CHRONIC INFLAMMATION; CONTROLLED STUDY; CULTURE TECHNIQUE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; MACROPHAGE ACTIVATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR IMMUNOLOGY; UPREGULATION;

BLOTTING, WESTERN; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; CYTOKINES; EPITHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; FLOW CYTOMETRY; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1;

EID: 60249084250     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.10.025     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics 2007. CA: A Cancer Journal for Clinicians 57 (2007) 43-66
2. De Marzo A.M., Platz E.A., Sutcliffe S., Xu J., Gronberg H., Drake C.G., Nakai Y., Isaacs W.B., and Nelson W.G. Inflammation in prostate carcinogenesis. Nature Reviews 7 (2007) 256-269
3. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
4. Dennis L.K., Lynch C.F., and Torner J.C. Epidemiologic association between prostatitis and prostate cancer. Urology 60 (2002) 78-83
5. Sarma A.V., McLaughlin J.C., Wallner L.P., Dunn R.L., Cooney K.A., Schottenfeld D., Montie J.E., and Wei J.T. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. The Journal of Urology 176 (2006) 1108-1113
6. Jacobs E.J., Rodriguez C., Mondul A.M., Connell C.J., Henley S.J., Calle E.E., and Thun M.J. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. Journal of the National Cancer Institute 97 (2005) 975-980
7. Mahmud S., Franco E., and Aprikian A. Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis. British Journal of Cancer 90 (2004) 93-99
8. Putzi M.J., and De Marzo A.M. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 56 (2000) 828-832
9. Montironi R., Mazzucchelli R., and Scarpelli M. Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention. Annals of the New York Academy of Sciences 963 (2002) 169-184
10. Schoppmann S.F., Birner P., Stockl J., Kalt R., Ullrich R., Caucig C., Kriehuber E., Nagy K., Alitalo K., and Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. The American Journal of Pathology 161 (2002) 947-956
11. Torisu H., Ono M., Kiryu H., Furue M., Ohmoto Y., Nakayama J., Nishioka Y., Sone S., and Kuwano M. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. International Journal of Cancer 85 (2000) 182-188
12. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nature Reviews 2 (2002) 301-310
13. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annual Review of Immunology 12 (1994) 141-179
14. Gasparian A.V., Yao Y.J., Kowalczyk D., Lyakh L.A., Karseladze A., Slaga T.J., and Budunova I.V. The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. Journal of Cell Science 115 (2002) 141-151
15. Sweeney C., Li L., Shanmugam R., Bhat-Nakshatri P., Jayaprakasan V., Baldridge L.A., Gardner T., Smith M., Nakshatri H., and Cheng L. Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clinical Cancer Research 10 (2004) 5501-5507
16. Park E.K., Jung H.S., Yang H.I., Yoo M.C., Kim C., and Kim K.S. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflammation Research 56 (2007) 45-50
17. Hevel J.M., and Marletta M.A. Nitric-oxide synthase assays. Methods in Enzymology 233 (1994) 250-258
18. Tobias P.S., and Ulevitch R.J. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 187 (1993) 227-232
19. Lin K.Y., Lu D., Hung C.F., Peng S., Huang L., Jie C., Murillo F., Rowley J., Tsai Y.C., He L., Kim D.J., Jaffee E., Pardoll D., and Wu T.C. Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion. Cancer Research 67 (2007) 1832-1841
20. Shariat S.F., Karam J.A., Walz J., Roehrborn C.G., Montorsi F., Margulis V., Saad F., Slawin K.M., and Karakiewicz P.I. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clinical Cancer Research 14 (2008) 3785-3791
21. Harkonen P.L., and Makela S.I. Role of estrogens in development of prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 92 (2004) 297-305
22. Ho S.M. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. Journal of Cellular Biochemistry 91 (2004) 491-503
23. Bonkhoff H., Fixemer T., Hunsicker I., and Remberger K. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. The American Journal of Pathology 155 (1999) 641-647
24. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nature Reviews 4 (2004) 71-78
25. Furman R.R., Asgary Z., Mascarenhas J.O., Liou H.C., and Schattner E.J. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. Journal of Immunology 164 (2000) 2200-2206
26. Houldsworth J., Mathew S., Rao P.H., Dyomina K., Louie D.C., Parsa N., Offit K., and Chaganti R.S. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 87 (1996) 25-29
27. Sovak M.A., Bellas R.E., Kim D.W., Zanieski G.J., Rogers A.E., Traish A.M., and Sonenshein G.E. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. The Journal of Clinical Investigation 100 (1997) 2952-2960
28. Cunha G.R., Wang Y.Z., Hayward S.W., and Risbridger G.P. Estrogenic effects on prostatic differentiation and carcinogenesis. Reproduction, Fertility, and Development 13 (2001) 285-296
29. Leav I., Merk F.B., Kwan P.W., and Ho S.M. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. The Prostate 15 (1989) 23-40